James A Reiffel

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. doi request reprint Rationale and design of REVEAL AF: a prospective study of previously undiagnosed atrial fibrillation as documented by an insertable cardiac monitor in high-risk patients
    James Reiffel
    Columbia University Medical Center, New York, NY Electronic address
    Am Heart J 167:22-7. 2014
  2. ncbi request reprint Antiarrhythmic effects of omega-3 fatty acids
    James A Reiffel
    Division of Cardiology, Department of Medicine, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York 10032, USA
    Am J Cardiol 98:50i-60i. 2006
  3. doi request reprint Demystifying the rate versus rhythm conundrum: new perspectives on recent trials and future treatment options. Introduction
    James A Reiffel
    Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Am J Cardiol 102:1H-2H. 2008
  4. ncbi request reprint Practical algorithms for pharmacologic management of the post myocardial infarction patient
    James A Reiffel
    Cardiology Division, Department of Medicine, Columbia University, New York, New York, USA
    Clin Cardiol 28:I28-37. 2005
  5. ncbi request reprint Atypical proarrhythmia with dofetilide: monomorphic VT and exercise-induced torsade de pointes
    James A Reiffel
    Electrophysiology Service, Department of Medicine, Division of Cardiology, Columbia University, New York, NY, USA
    Pacing Clin Electrophysiol 28:877-9. 2005
  6. ncbi request reprint Drug and drug-device therapy in heart failure patients in the post-COMET and SCD-HeFT era
    James A Reiffel
    Department of Medicine, Columbia University Medical Center, New York, NY 10032, USA
    J Cardiovasc Pharmacol Ther 10:S45-58. 2005
  7. ncbi request reprint Comparison of autotriggered memory loop recorders versus standard loop recorders versus 24-hour Holter monitors for arrhythmia detection
    James A Reiffel
    Division of Cardiology, Department of Medicine, Columbia University, New York, New York 10032, USA
    Am J Cardiol 95:1055-9. 2005
  8. doi request reprint A contemporary look at classic trials in atrial fibrillation: what do they really show and how might they apply to future therapies?
    James A Reiffel
    Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Am J Cardiol 102:3H-11H. 2008
  9. doi request reprint Cardioversion for atrial fibrillation: treatment options and advances
    James A Reiffel
    Department of Medicine, Division of Cardiology, Section of Electrophysiology, Columbia University, New York, New York 10032, USA
    Pacing Clin Electrophysiol 32:1073-84. 2009
  10. ncbi request reprint Formulation substitution: a frequently overlooked variable in cardiovascular drug management
    James A Reiffel
    Division of Cardiology, Department of Medicine, Columbia University College of Physicians and Surgeons, The New York Presbytarian Hospital, New York, NY, USA
    Prog Cardiovasc Dis 47:3-10. 2004

Detail Information

Publications27

  1. doi request reprint Rationale and design of REVEAL AF: a prospective study of previously undiagnosed atrial fibrillation as documented by an insertable cardiac monitor in high-risk patients
    James Reiffel
    Columbia University Medical Center, New York, NY Electronic address
    Am Heart J 167:22-7. 2014
    ..The incidence of AF in high-risk patients, understanding how physicians manage these patients once AF has been detected, and knowing which patient characteristics are most predictive of developing AF are all unknown...
  2. ncbi request reprint Antiarrhythmic effects of omega-3 fatty acids
    James A Reiffel
    Division of Cardiology, Department of Medicine, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York 10032, USA
    Am J Cardiol 98:50i-60i. 2006
    ....
  3. doi request reprint Demystifying the rate versus rhythm conundrum: new perspectives on recent trials and future treatment options. Introduction
    James A Reiffel
    Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Am J Cardiol 102:1H-2H. 2008
  4. ncbi request reprint Practical algorithms for pharmacologic management of the post myocardial infarction patient
    James A Reiffel
    Cardiology Division, Department of Medicine, Columbia University, New York, New York, USA
    Clin Cardiol 28:I28-37. 2005
    ..Current guidelines also recommend that patients post MI with elevated cholesterol levels should be prescribed lipid therapy with a statin at hospital discharge...
  5. ncbi request reprint Atypical proarrhythmia with dofetilide: monomorphic VT and exercise-induced torsade de pointes
    James A Reiffel
    Electrophysiology Service, Department of Medicine, Division of Cardiology, Columbia University, New York, NY, USA
    Pacing Clin Electrophysiol 28:877-9. 2005
    ....
  6. ncbi request reprint Drug and drug-device therapy in heart failure patients in the post-COMET and SCD-HeFT era
    James A Reiffel
    Department of Medicine, Columbia University Medical Center, New York, NY 10032, USA
    J Cardiovasc Pharmacol Ther 10:S45-58. 2005
    ....
  7. ncbi request reprint Comparison of autotriggered memory loop recorders versus standard loop recorders versus 24-hour Holter monitors for arrhythmia detection
    James A Reiffel
    Division of Cardiology, Department of Medicine, Columbia University, New York, New York 10032, USA
    Am J Cardiol 95:1055-9. 2005
    ..Further, the higher yield of AT-MLR versus MLR demonstrates the significantly enhanced benefit of autotriggered programmable recording...
  8. doi request reprint A contemporary look at classic trials in atrial fibrillation: what do they really show and how might they apply to future therapies?
    James A Reiffel
    Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Am J Cardiol 102:3H-11H. 2008
    ..Importantly, as the armamentarium of AF management strategies is broadened, the risk/efficacy balance must continue to be evaluated on a patient-specific basis...
  9. doi request reprint Cardioversion for atrial fibrillation: treatment options and advances
    James A Reiffel
    Department of Medicine, Division of Cardiology, Section of Electrophysiology, Columbia University, New York, New York 10032, USA
    Pacing Clin Electrophysiol 32:1073-84. 2009
    ..In conclusion, further trials should clarify the long-term safety profiles of new atrioselective agents and other investigational drugs and define their role in the treatment of AF...
  10. ncbi request reprint Formulation substitution: a frequently overlooked variable in cardiovascular drug management
    James A Reiffel
    Division of Cardiology, Department of Medicine, Columbia University College of Physicians and Surgeons, The New York Presbytarian Hospital, New York, NY, USA
    Prog Cardiovasc Dis 47:3-10. 2004
  11. ncbi request reprint Have sanctioned algorithms replaced empiric judgment in the selection process of antiarrhythmic drugs for the therapy for atrial fibrillation?
    James A Reiffel
    Columbia Presbyterian Hospital, Division of Cardiology, 161 Fort Washington Avenue, New York, NY 10032, USA
    Curr Cardiol Rep 6:365-70. 2004
    ....
  12. ncbi request reprint Is arterial stiffness a contributing factor to atrial fibrillation in patients with hypertension? A preliminary investigation
    James A Reiffel
    Division of Cardiology, Department of Medicine, Columbia University and The New York Presbyterian Hospital, 161 Fort Washington Avenue, New York, NY 10032, USA
    Am J Hypertens 17:213-6. 2004
    ..Alternatively, it may be a more indirect and complex relationship involving chronic morphologic, electrophysiologic, and secretory consequences in the atrium consequent to a chronically reduced left ventricular (LV) compliance...
  13. ncbi request reprint Will direct thrombin inhibitors replace warfarin for preventing embolic events in atrial fibrillation?
    James A Reiffel
    Department of Clinical Medicine, Columbia University, New York, New York, USA
    Curr Opin Cardiol 19:58-63. 2004
    ....
  14. doi request reprint Practice patterns among United States cardiologists for managing adults with atrial fibrillation (from the AFFECTS Registry)
    James A Reiffel
    Columbia University, New York, NY, USA
    Am J Cardiol 105:1122-9. 2010
    ..In conclusion, data from this study provide insight into community treatment patterns in patients with AF, most without clinically significant structural heart disease or with only uncomplicated hypertension...
  15. doi request reprint Atrial fibrillation: what have recent trials taught us regarding pharmacologic management of rate and rhythm control?
    James A Reiffel
    Department of Medicine, Division of Cardiology, Electrophysiology Section, Columbia University Medical Center, New York, New York 10032, USA
    Pacing Clin Electrophysiol 34:247-59. 2011
    ..This review examines the clinical outcomes of several important AF trials, discusses the limitations in applying the major morbidity/mortality findings to everyday clinical practice, and summarizes the lessons learned...
  16. ncbi request reprint Adjunctive therapy for recurrent ventricular tachycardia in patients with implantable cardioverter defibrillators
    James A Reiffel
    Columbia University, 161 Fort Washington Avenue, New York, NY 10032, USA
    Curr Cardiol Rep 9:381-6. 2007
    ..This review describes the considerations important to the use of these therapies in ICD patients and the results and applicability of these investigative studies...
  17. ncbi request reprint Antiarrhythmic drug therapy for atrial fibrillation: are the guidelines guiding clinical practice?
    James A Reiffel
    Columbia University Medical Center, 161 Fort Washington Ave, New York, NY 10032, USA
    Clin Cardiol 29:97-102. 2006
    ..However, market research and clinical study data indicate a growing use of class III agents (mainly amiodarone) despite long-term safety and tolerability concerns, suggesting that clinical practice does not adhere to current guidelines...
  18. ncbi request reprint Autonomic modulation of the u wave during sympathomimetic stimulation and vagal inhibition in normal individuals
    Anthony R Magnano
    Department of Medicine, Division of Cardiology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Pacing Clin Electrophysiol 27:1484-92. 2004
    ..Thus, the U wave represents a component of cardiac repolarization that is electrocardiographically and physiologically distinct from the T wave with a unique response to sympathomimetic stimulation...
  19. doi request reprint Device therapies in the post-myocardial infarction patient with left ventricular dysfunction
    Alan H Kadish
    Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA
    Am J Cardiol 102:29G-37G. 2008
    ..Further risk stratification studies of post-MI LVD patients will allow ICD therapy to be applied in a more cost-effective manner...
  20. doi request reprint Drug therapy for atrial fibrillation: what will its role be in the era of increasing use of catheter ablation?
    John P Morrow
    Department of Medicine, Division of Cardiology, New York Presbyterian Hospital, Columbia University, New York, NY 10032, USA
    Pacing Clin Electrophysiol 32:108-18. 2009
    ..If ablation techniques improve, one might ask whether there will still be a role for AADs, and, if so, what will it be and what agents will be used. This manuscript will attempt to answer these questions...
  21. ncbi request reprint New antiarrhythmic drugs for establishing sinus rhythm in atrial fibrillation: what are our therapies likely to be by 2010 and beyond?
    John P Morrow
    The Division of Cardiology, Department of Medicine, Columbia University, New York, NY, USA
    Am Heart J 154:824-9. 2007
    ....
  22. ncbi request reprint The potential for changing prescribing patterns from warfarin to oral direct thrombin inhibitors: clinical scenarios
    James A Reiffel
    Department of Medicine, Division of Cardiology, Columbia University College of Physicians and Surgeons, New York, New York, USA
    Rev Cardiovasc Med 5:S12-21. 2004
    ..Therefore, clinicians should diligently follow the medical literature regarding the latest information on this agent...
  23. doi request reprint Cross-trial comparisons: a source of confusion, use, or both in the management of patients with atrial fibrillation?
    Vivek Iyer
    Division of Cardiology, Department of Medicine, Columbia University, New York, NY 10032, USA
    Am Heart J 165:882-92. 2013
    ..Using trials investigating therapies for atrial fibrillation, we attempt to highlight the important points for practitioners to consider when making these comparative intertrial judgments...
  24. doi request reprint Dabigatran: comparison to warfarin, pathway to approval, and practical guidelines for use
    Vivek Iyer
    Department of Medicine, Division of Cardiology, Columbia University Medical Center, NY 10032, USA
    J Cardiovasc Pharmacol Ther 17:237-47. 2012
    ..We conclude by proposing a role for dabigatran in the armamentarium of drugs available for the management of stroke risk in AF...
  25. ncbi request reprint Microcomplex--a new incomplete heart block pattern
    James A Reiffel
    Cardiology Division, Department of Medicine, Columbia University, NYC, NY, USA
    J Electrocardiol 35:273-8. 2002
    ....
  26. ncbi request reprint Autonomic nervous system influences on QT interval in normal subjects
    Anthony R Magnano
    Department of Medicine, Division of Cardiology, Columbia University College of Physicians and Surgeons, 630 West 168th Street, New York, NY 10032, USA
    J Am Coll Cardiol 39:1820-6. 2002
    ..We sought to determine whether the relationship between heart rate (HR) and QT interval (QT) differs as HR increases in response to exercise, atropine and isoproterenol...
  27. ncbi request reprint Cardiology patient page. The implantable cardioverter-defibrillator: patient perspective
    James A Reiffel
    Division of Cardiology, Division of Medicine, Columbia University, and the New York Presbyterian Hospital, New York, NY, USA
    Circulation 105:1022-4. 2002